STAT Plus What does Glaxo get with its Tesaro deal Heres what the wags are saying
STAT Plus: What does Glaxo get with its Tesaro deal? Here’s what the wags are saying
15:50 EST 3 Dec 2018 |
STAT
The acquisition enhances the Glaxo pipeline and, notably, returns the company to the commercial cancer business.
More From BioPortfolio on "STAT Plus: What does Glaxo get with its Tesaro deal? Here’s what the wags are saying"